ArticleFrontiers in pharmacology2019

Anti-tumor Efficacy Assessment of the Sigma Receptor Pan Modulator RC-106. A Promising Therapeutic Tool for Pancreatic Cancer.

Anna Tesei et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.